STARKVILLE, Miss.—A local physician is the recipient of an inaugural award presented by Mississippi State’s Healthcare Pathways Resource Center, a support service for university students and alumni ...

As the biochemical basis of asthma is not yet fully understood, researchers from The Catholic University of Korea, the Korea University College of Medicine, and Seoul National University (all in Seoul ...

Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has published the Guideline for Management of Multiple Sclerosis (MS). Developed in collaboration with the National Multiple ...

These biomarker changes occurred alongside clinical stabilization or improvement, with no serious treatment-related adverse events.

Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late ...

Can you describe how the untargeted ultrahigh-performance liquid chromatography–high resolution tandem mass spectrometry (UHPLC–HRMS/MS) workflow was designed to capture both known salicylates and ...

Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, from the complex and often prolonged road to diagnosis to the substantial ...

Today, the American Diabetes Association(R) (ADA) announced the awardees of the 2026 Pathway to Stop Diabetes(R) (Pathway) Award grants. The seven new awards, totaling $11.3 million in strategic ...

Mr. Jackson’s presidential campaigns created a pathway for scores of Black Democrats to run for office, with many making ...

A new footpath would veer school kids away from a dangerous thoroughfare and create an alternative pathway for pedestrians and cyclists travelling between Brinsmead and Freshwater.

TMEM97 regulates microglial activation and neuronal stress pathways linked to neuropathic pain and neuroinflammation in multiple sclerosis (MS). Pharmacological targeting of TMEM97 has shown ...

Manuel A. Friese, MD, clinician-scientist at the Institute of Neuroimmunology and Multiple Sclerosis of the University Medical Center Hamburg-Eppendorf in Hamburg, Germany was awarded the 2025 ...